跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,193 条关于
“Ark Biopharmaceutical”
全部
10,193
临床试验
6,210
药物
660
机构
363
资讯
2,960
7个月前
ArkBio Receives FDA Clearance for Phase 2 Trial of Novel Anti-Fibrotic Drug AK3280 in Idiopathic Pulmonary Fibrosis
5个月前
ArkBio Initiates First-in-Human Trial of Novel Long-Acting Influenza Drug AK0406 in Australia
上个月
ArkBio's RSV Antiviral Ziresovir Receives FDA Approval for Phase II Trial in Critically Ill Infants
10个月前
ArkBio Launches Phase II Trial of AK0610 Monoclonal Antibody for RSV Prevention in Infants
上个月
ArkBio Completes All Cohort Dosing in Australian Phase I Trial of Novel Long-Acting Influenza AFC Drug AK0406
去年
WHO Includes ArkBio's Ziresovir in Pediatric RSV Drug Priority List, Marking First Chinese Anti-RSV Drug Recognition
8个月前
China Approves Azstarys for ADHD Treatment, Offering First Dual-Mechanism Therapy for 23 Million Affected Patients
去年
ArkBio's AK3280 Shows Promising Results in Phase II IPF Trial with Significant Lung Function Improvement
去年
ArkBio's AK0901 Completes Phase III Trial for ADHD in China, Showing Significant Efficacy
去年
Ark Clinical Research Launches Mobile Unit to Enhance Decentralized Clinical Trials and Diversity
第 1 页,共 296 页
上一页
下一页